Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children

By sjmartinez • January 9, 2025

Simpson EL, Hebert AA, Browning J, Serrao RT, Sofen H, Brown PM, Piscitelli SC, Rubenstein DS, Tallman AM. Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children. Dermatol Ther (Heidelb). 2025 Jan 7. doi: 10.1007/s13555-024-01318-6. Epub ahead of print. PMID: 39777610.

Tags: atopic dermatitis, Dermatology, Family impact, Olive View DoM, patient-reported outcomes, Publications, Quality of Life, Sleep improvement, Tapinarof cream 1% once daily, Topical aryl hydrocarbon receptor agonist

Evidence of neuronal DNA damage in the brains of patients with Rett syndrome

Morales A, Korsakova E, Mansooralavi N, Soliman P, Jahanbani S, Olsen ML, Badhuri A, Lowry WE. Evidence of neuronal DNA damage in the brains of[...]

Multi-omics signature of healthy versus unhealthy lifestyles reveals associations with diseases

Fu G, Rushing BR, Graves L, Nieman DC, Pellegrini M, Soldano M, Thompson MJ, Sakaguchi CA, Pathmasiri W, Sumner SJ. Multi-omics signature of healthy versus[...]

Evaluating the impact of altitudinal variations on COVID-19 mortality rates: a comprehensive analysis

Karsli E, Metin DA, Kocatas A, Ercan FF, Sabirli R, Koseler A, Pellegrini M. Evaluating the impact of altitudinal variations on COVID-19 mortality rates: a[...]